DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Objections
Claim 1 is objected to because of the following informalities: claim 1 recites “Ph” which appears to be “pH”. Appropriate correction is required.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In this case, claim 1 recites “A method for purification of manganese pregnant leach solution (PLS) using solvent extraction (SX), the method comprising the steps of: providing a partially purified acidic aqueous pregnant leach solution (PLS)”, one of ordinary skill in the art is uncertain what is the relationship of such “partially purified acidic aqueous pregnant leach solution” as compared to the previously recited “manganese pregnant leach solution”, i.e. such partially purified acidic aqueous pregnant leach solution containing which material as pregnant leach solution?
Secondly, claim 1 recites “a stronger acid”. The term “stronger acid” in claim 1 is a relative term which renders the claim indefinite. The term “stronger acid” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, i.e., such as what acid can be considered as “stronger acid”, or “stronger acid” is based on what standard and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Thirdly, claim 1 recites “a weaker acid”. Similarly, the term “weaker acid” in claim 1 is a relative term which renders the claim indefinite. The term “weaker acid” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, i.e., such as what acid can be considered as “weaker acid”, or “weaker acid” is based on what standard and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention.
Fourthly, claim 1 first recites “calcium and magnesium impurities”, then recites “metal impurities”, one of ordinary skill in the art is uncertain what is the relationship between such recited “calcium and magnesium impurities” and “metal impurities”, do they refer to the same impurities or metal impurities comprising calcium and magnesium but also other metal elements?
Fifthly, claim 1 recites “substantially free of metal impurities” and “substantially free of alkaline elements”, The term “substantially free of” in claim 1 is a relative term which renders the claim indefinite. The term “substantially free of” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, i.e., how low of metal or alkaline element content can be considered as “substantially free of”, or “substantially free of” is based on what standard and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention.
Sixthly, claim 1 recites “alkaline elements”, one of ordinary skill in the art is uncertain what elements can be considered as “alkaline elements”, such as any basic compound or materials, such as hydroxide, or calcium hydrogen carbonate or ammonia, or applicant trying to say “alkaline earth elements”? If applicant trying to refer “alkaline earth elements”, then what is the relationship of such recited “alkaline elements” as compared to previously recited calcium and magnesium?
Seventhly, claim 1 recites “a clean aqueous phase”, what type of aqueous phase or aqueous material can be considered as “a clean aqueous phase”?
Lastly, claim 1 recites “high purity manganese sulfate monohydrate”, such term “high purity manganese sulfate monohydrate” is a relative term, which renders the claim indefinite. The term “high purity manganese sulfate monohydrate” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, i.e., how high content of manganese sulfate monohydrate or how much purity of such material can be considered as “high purity manganese sulfate monohydrate”, or “high purity manganese sulfate monohydrate” is based on what standard of purity and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention.
All claim 1’s depending claims are rejected for similar reasons.
Claim 4 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In this case, claim 4 recites “a phosphinic acid derivative”, one of ordinary skill in the art is uncertain what exact material or compound can be considered as “a phosphinic acid derivative”, such as any material produced/made from a phosphinic acid, or any compound having a phosphinic acid backbone but certain groups being modified with other functional groups? Therefore, one of ordinary skill in the art cannot ascertain the metes and bounds of such claimed limitations.
Conclusion
The prior art made of record is considered pertinent to applicant's disclosure. For example, Du to (CN109133178) appears to be the closest prior art, Du teaches a manganese sulphate production process comprising providing a partially purified aqueous manganese pregnant solution (after Step 1 and 2, Fig. 1) extracting using a P507 organic extracting agent and a raffinate comprising calcium impurities, and collecting an oil phase to prepare a manganese-loaded organic phase; carrying out back extraction on the manganese loaded organic phase by using sulfuric acid, and collecting a water phase to prepare a manganese sulphate solution; and carrying out an evaporative crystallization, centrifugal dehydration and drying on the manganese sulphate solution to obtain a manganese sulphate product (claim 1-3,examples 1-6, Fig. 1) . Du also teaches in the organic extractant step comprising adding 2- ethylhexyl phosphoric acid mono-2-ethylhexyl into sulfonated kerosene, stirring uniformly, then adding sodium hydroxide solution, stirring and saponifying to obtain the 2-ethylhexyl phosphoric acid mono-2-ethylhexyl organic extractant. But Du does not expressly teach a barren aqueous phase comprising calcium and magnesium impurities, or producing manganese sulphate monohydrate (HPMSM) crystals as that of instantly claimed. Jiang et al. to (US2012/0321546) discloses using adding proper amount of hydrogen peroxide to the MnSO4 solution, heating to boiling, adjusting the pH value of the solution within 5-6, evaporation the filtrate after a precise filtration, and crystallizing and drying to obtain MnSO4·H2O product.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JUN LI whose telephone number is (571)270-5858. The examiner can normally be reached IFP.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Ching-Yiu (Coris) Fung can be reached at 571-270-5713. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JUN LI/ Primary Examiner, Art Unit 1732